Immune homeostasis requires the tight, tissue-specific control of the different CD4 + Foxp3 + regulatory T (Treg) cell populations. 
Introduction
Foxp3-expressing regulatory T (Treg) cells are essential for immune homeostasis, especially in the gut. However, Treg cells can also contribute to pathogenesis, most notably by inhibiting protective immune responses to tumours in mice and humans.
1 Therefore Treg cells must be kept under strict control. We and others have previously shown that intestinal Treg cells can be regulated differently to Treg cells in other organs. [2] [3] [4] [5] [6] Gut Treg cells express high levels of CD103 and/or the killer cell lectinlike receptor G1 (KLRG1), the two known heterotypic receptors for E-cadherin, a key component of epithelial intercellular junctions. [7] [8] [9] Both receptors have been associated with activated Treg cells, and KLRG1 has been specifically associated with a population of effector Treg cells expressing GATA3 + in the gut.
10
KLRG1 is an inhibitory receptor found on several immune subsets, most notably on natural killer cells and activated CD8 + T cells, and it is used as a marker for exhausted CD8 + T cells. 11, 12 It has been described to bind cadherin family members, including E-, N-and R-cadherins. 13 Our knowledge about KLRG1 function comes mainly from its interactions with E-cadherin, as most cellular analyses were performed with E-cadherin-expressing cells. Cross-linking T-cell receptor (TCR) and KLRG1 has been shown to have an inhibitory role on TCR-mediated signals.
14 Like many inhibitory receptors, KLRG1 is 
I M M U N O L O G Y O R I G I N A L A R T I C L E
expressed by Treg cells but, in contrast to the inhibitory receptor CTLA-4, it is not found on every Treg cell but only on a subpopulation of effector-like Treg cells. [8] [9] [10] Although KLRG1 is often used as a marker for effector Treg cells, it has not been investigated whether and how it affects Treg cells.
Here we analyse the Treg cell population from KLRG1-deficient animals. In line with the lack of phenotype of KLRG1 knockout (KO) mice, we found that KLRG1-deficient animals have normal frequencies of Treg cells, also in the gut. The frequencies of the effector GATA3 + gut Treg population, which exhibit high levels of KLRG1, are similarly unaltered in KLRG1 KO mice. We also show that KLRG1 engagement with an antibody reduces Treg cell accumulation in response to TCR signals in vitro, and that under competitive settings KLRG1 limits Treg cell accumulation in the gut in a cell-autonomous manner. Hence, although KLRG1 is dispensable for the functioning of the total Treg population, it can affect the survival potential of individual Treg cells in the gut.
Materials and methods

Mouse strains
Wild-type C57BL/6, congenic B6.SJL-Cd45, C57BL/6 Klrg1 À/À15 and C57BL/6 Rag2 À/À mice were kept and bred under specific pathogen-free conditions at the animal facility of the Max-Planck Institute of Immunobiology and Epigenetics. All experiments were approved by the institutional review board of the Max Planck Institute of Immunobiology and Epigenetics and the local government in Freiburg.
Isolation of leucocytes from the lamina propria
Leucocytes from the lamina propria were isolated as described previously. 4, 16 Briefly, small intestine and colon were removed and cleaned. After washing with ice-cold PBS, intestines were washed twice in Hanks' balanced salt solution containing 5 mM EDTA and 10 mM HEPES at 37°t o remove the epithelial cell layer. The tissue was then minced finely and digested three times in Hanks' balanced salt solution containing dispase (5 units/ml; BD Biosciences, Franklin Lakes, NJ, USA), collagenase IV (0Á5 mg/ ml; Worthington, Lakewood, NJ) and DNaseA (0Á5 mg/ml; AppliChem, Darmstadt, Germany), at 37°with constant shaking. Supernatants were collected and lymphocytes were enriched after a gradient centrifugation using buffered Percoll (GE Healthcare, Freiburg, Germany).
Antibodies and flow cytometry
Single-cell suspensions were stained in 96-well plates (10 6 cells/well). The following conjugated antibodies were purchased from eBioscience (Affymetrix, Inc., Santa Clara, CA, USA): TCR-b (H57-597), CD3 (145-2C11), CD4 (GK 1.5), KLRG1 (2F1), CD103 (2E7), CD45.1 (A20), CD45.2 (104), CD25 (PC61.5), Foxp3 (FJK-16s) and Nur77 (12.14) . Intracellular staining was performed with the eBioscience permeabilization and fixation kit. Anti-Bcl-2 (3F11) was purchased from BD Biosciences. Dead cells were excluded by staining with Fixable Viability Dye (eBioscience). All flow cytometry experiments were acquired using a BD LSR II cytometer or LSR Fortessa (BD Biosciences). FLOW JO Version 8.8.7 (Treestar Inc., Ashland, OR) was used for data analysis.
Bone marrow chimeras
Recipient CD45.1 + B6.SJL-Cd45 mice were irradiated (2 9 300 Rad) and reconstituted 12 hr later using intravenous injection of CD45. . Two groups of mice were generated (KLRG1 KO + congenic bone marrow, control C57BL/6 + congenic bone marrow). Mice were analysed 6-8 months after reconstitution.
Prevention of colitis
Naive and Treg cells from C57BL/6 or KLRG1 KO mice were sorted as described. 4 4 Briefly, each sample was graded semi-quantitatively from 0 to 3 for the four following criteria: degree of epithelial hyperplasia and goblet cell depletion; leucocyte infiltration in the lamina propria; area of tissue affected; and the presence of markers of severe inflammation such as crypt abscesses, submucosal inflammation and ulcers. Scores for each criterion were added to give an overall inflammation score for each sample of 0-12. The total colonic score was calculated as the average of the individual scores from the sections of proximal colon, mid-colon and distal colon.
Images were obtained using Plan-Neofluar 5 9 0Á15 or 10 9 0Á30 objectives on a Zeiss Axioplan II with AXIOVS40 V4.8.2.0 software connected to a camera AxioCam MR5 (Carl Zeiss, Jena, Germany). 
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Statistical analysis
Statistical analysis was performed using GRAPHPAD PRISM using a two-tailed unpaired Student's t-test when only two groups were tested, or analysis of variance with Bonferroni
Post-test where more than two groups were tested. Differences were considered statistically significant when P < 0Á05.
Results
KLRG1 is not essential for Treg cell generation or function
We checked the expression of the two E-cadherin receptors on Treg cells. As described previously, 9 KLRG1 and CD103 can be co-expressed on Treg cells (Fig. 1a) and are found mostly in the gut (Fig. 1b,c) ; however, the frequency of KLRG1 + Treg cells was lower than the frequency of CD103
+
Treg cells in all organs tested (Fig. 1b) , and the fraction of KLRG1 + among Treg cells declined with age (Fig. 1d) . On the other hand, the per cell levels of KLRG1 on intestinal Treg, as measured by flow cytometry, were higher than for other intestinal KLRG1-expressing populations, such as CD8 + and ILC2 cells (Fig. 1e) . The high KLRG1 expression suggests that KLRG1 can play a role in Treg cells.
We therefore assessed the frequencies of Treg cells in KLRG1 KO mice, comparing them with KLRG1-expressing KLRG1 heterozygote littermates. KLRG1 KO mice 15 do not develop spontaneous inflammation, suggesting that KLRG1 is not essential for Treg cell generation. As KLRG1 inhibits TCR signals, 14 and TCR is important for Treg cell accumulation, 17, 18 we hypothesized that KLRG1 KO mice might have altered Treg cell frequencies. However, KLRG1 KO mice did not show an increase in intestinal Treg cells (Fig. 2a) . When we assessed the frequencies of CD103 + Treg cells, we found a small increase in the colon of KLRG1 KO mice compared with control BL/6 (Fig. 2b) . This increase did not take place in the spleen, mesenteric lymph nodes or small intestine. (Fig. 2c) . Similarly, the frequencies of GATA3 + Treg cells, a subset characterized by high KLRG1 expression, 10 were comparable in KLRG1 KO mice and control littermates (Fig. 2d) .
We then tested the ability of KLRG1 KO Treg cells to prevent inflammation in an established model of T-cell transfer-mediated colitis. In this system, where inflammation is absent, KLRG1 is expressed by Treg cells in the protected mice (see refs 10 and 19, and Fig. 2e) ; however, KLRG1 KO Treg cells accumulated and prevented colitis in a similar way to control Treg cells (Fig. 2e) . KLRG1 KO Treg cells also suppressed T-cell proliferation in vitro as efficiently as control Treg cells (Fig. 2f) . Hence, KLRG1 is dispensable for the protective ability of Treg cells. Together, our data show that KLRG1 is dispensable for Treg cell generation and function.
KLRG1 ligation reduces TCR signals and Treg cell accumulation in vitro
KLRG1 ligation by 2F1 antibody or by E-cadherin inhibits TCR signalling in a reporter cell line model. 14 As KLRG1 + Treg cell lines are not available, we used ex vivo T cells to assess the effects of KLRG1 ligation by 2F1 antibody. We used Nur77 as a proxy for the strength of TCR stimulation. 20 We found that, as found for the reporter cell line, KLRG1 ligation during stimulation with anti-CD3 reduces TCR signalling intensity in KLRG1 + but not in KLRG1
À Treg cells (Fig. 3a) . TCR signals are necessary
for Treg cell accumulation, 17,18 and we found this to be the case also in our in vitro system (Fig. 3b) . Accordingly, in vitro KLRG1 ligation reduced KLRG1 + Treg cell accumulation, but it did not affect KLRG1 À Treg cells. ( Fig. 3c) . These data indicate that KLRG1 can negatively impact Treg cell accumulation.
KLRG1 limits gut Treg cell accumulation in competitive settings
The in vitro data showing that KLRG1 ligation reduces Treg cell accumulation were at odds with our initial finding that KLRG1 KO mice do not have increased Treg cell frequencies in the gut. The size of the Treg cell pool is tightly controlled by interleukin-2 and other factors, and Treg cells have a very high homeostatic capacity. 21 We reasoned that homeostatic processes could obscure the effect of KLRG1 on Treg cells. To assess this point, we checked the competitive ability of KLRG1 KO Treg cells in mixed bone marrow chimeras where the cells could be tracked with congenic markers. To this end we generated two sets of chimeras, one with KLRG1 KO and another one with control C57BL/6 bone marrow cells, mixed with congenic bone marrow cells. KLRG1 KO and control C57BL/6 cells were CD45,2 + , whereas congenic bone marrow, as well as potential residual host cells, were CD45,1 + in both chimeras. These chimeras had comparable frequencies of CD4 + T cells and Foxp3 + Treg cells among CD4 + in spleen, mesenteric lymph nodes and colon (Fig. 4a) . When we checked the origin of the cells by comparing the frequency of CD45.2 + cells in the two different chimeras, we found that KLRG1 KO-derived Treg cells accumulated better than control Treg cells in the colon, but not in the spleen or mesenteric lymph nodes (Fig. 4b) . The data show that KLRG1 deficiency on Treg cells confers on them a competitive advantage to accumulate in the gut, supporting a cell-intrinsic role for KLRG1 in gut Treg cell homeostasis. The effect was not only organ-restricted, but also specific for Treg cells, as CD4 + Foxp3 À cell accumulation was not strongly influenced by the lack of KLRG1 (Fig. 4b) . Hence, KLRG1 plays a cell-intrinsic role in gut Treg cell homeostasis, but it does not alter the size of the total Treg cell pool.
Discussion
Inhibitory receptors are key to the functioning of the immune system. Their absence can have drastic effects such as with the inhibitory receptor CTLA-4, where KO mice suffer from early lethal autoimmunity. 22 However, in many cases the absence of the inhibitory receptors is compensated by homeostatic factors and does not lead to 24 Both E-cadherin and N-cadherin have been reported to act as ligands for KLRG1 in reporter cell assays, but only E-cadherin has been shown to induce KLRG1-mediated inhibition in functional assays so far. E-cadherin is typically expressed by epithelial cells, which represent the most abundant source of E-cadherin in the gut. They can also express MHC-II, so they could potentially act as antigen presenters to Treg cells. However, populations of MHC-II + myeloid cells expressing E-cadherin that could ligate both TCR and KLRG1 are also present in the intestine. 25 The relevance of different antigen-presenting populations in controlling gut Treg cells remains to be determined.
Treg cells are key supervisors of appropriate immune responses, and their role is especially important in the intestine. The local composition of the Treg cell population in the gut is not only controlled by food and commensal microbiota, 26 but also by intrinsic factors. Our data here show that KLRG1 affects the competitive fitness of individual intestinal Treg cells, suggesting that KLRG1 could be used as a target to manipulate gut Treg cells.
